BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 944260)

  • 1. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dopamine in withdrawal jumping in morphine dependent rats.
    Bläsig J; Gramsch C; Laschka E; Herz A
    Arzneimittelforschung; 1976; 26(6):1104-6. PubMed ID: 989389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of striatal and nonstriatal dopamine in opiate withdrawal.
    Herz A; Bläsig J; Laschka E; Gramsch C
    Adv Biochem Psychopharmacol; 1977; 16():597-9. PubMed ID: 560794
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.
    Gellert VF; Sparber SB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):44-54. PubMed ID: 557543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical absence of aggression during naloxone-precipitated morphine withdrawal.
    Gianutsos G; Hynes MD; Drawbaugh RB; Lal H
    Psychopharmacologia; 1975 Jul; 43(1):43-6. PubMed ID: 1172256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
    Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
    Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
    Iorio LC; Deacon MA; Ryan EA
    J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
    Iwamoto ET; Ho IK; Way EL
    J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
    [No Abstract]   [Full Text] [Related]  

  • 17. Naloxone increases vascular responsiveness in chronic morphine treated rats and facilitates intracellular signaling in cultured vascular cells.
    Wang Y; Xu JG; Yu YQ; Wang HY; Jiang B; Li XY
    Acta Pharmacol Sin; 2001 Oct; 22(10):881-6. PubMed ID: 11749769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
    Martin JR; Takemori AE
    J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.